Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis

Yuhua Fan, Jian Yu, Hongbing Chen, Jian Zhang, Jiangang Duan, Dapeng Mo, Wenhao Zhu, Bo Wang, Fubing Ouyang, Yicong Chen, Linfang Lan, Jinsheng Zeng, Chinese Stroke Association Stroke Council CVST Guideline Writing Committee, Yongjun Wang, Jizong Zhao, Anding Xu, Kangning Chen, Junbo Ge, Li Guo Li He, Bo Hu, Yong Huo, Linong Ji, Xunming Ji, Tielin Li, Liping Liu, Benyan Luo, Zhongrong Miao, Xiaoyuan Niu, Bin Peng, Dingfeng Su, Beisha Tang, Chen Wang, Ning Wang, Shuo Wang, Wei Wang, Xin Wang, Yilong Wang, Shizheng Wu, Peng Xie, Yuming Xu, Yun Xu, Yi Yang, Chaodong Zhang, Tong Zhang, Zhuo Zhang, Gang Zhao, Xingquan Zhao, Yuhua Fan, Jian Yu, Hongbing Chen, Jian Zhang, Jiangang Duan, Dapeng Mo, Wenhao Zhu, Bo Wang, Fubing Ouyang, Yicong Chen, Linfang Lan, Jinsheng Zeng, Chinese Stroke Association Stroke Council CVST Guideline Writing Committee, Yongjun Wang, Jizong Zhao, Anding Xu, Kangning Chen, Junbo Ge, Li Guo Li He, Bo Hu, Yong Huo, Linong Ji, Xunming Ji, Tielin Li, Liping Liu, Benyan Luo, Zhongrong Miao, Xiaoyuan Niu, Bin Peng, Dingfeng Su, Beisha Tang, Chen Wang, Ning Wang, Shuo Wang, Wei Wang, Xin Wang, Yilong Wang, Shizheng Wu, Peng Xie, Yuming Xu, Yun Xu, Yi Yang, Chaodong Zhang, Tong Zhang, Zhuo Zhang, Gang Zhao, Xingquan Zhao

Abstract

Aim: Cerebral venous sinus thrombosis (CVST) is a less common cerebrovascular disease that predominantly affects young patients. The incidence of CVST is 2-5/10 000 000/year, accounting for 0.5%-1% of all stroke. To reduce mortality and morbidity associated with CVST, Chinese Stroke Association commissioned the authors to write the current guideline on the management of CVST.

Methods: PubMed (MEDLINE), CNKI and Wanfang database were searched for studies related to CVST from 1 January 1990 to 31 July 2019. Data were synthesised by evidence tables. Each recommendation was fully discussed by the writing group members and reviewed by Chinese Stroke Association Stroke Fellow Committees. Levels of evidence grading algorithm of Chinese Stroke Association was used to grade each recommendation.

Results: This guideline mainly focuses on the diagnostic evaluation, therapeutic strategies and secondary prevention of CVST. CT/CTV and MRI/MRV are recommended in the initial imaging evaluation of patients with suspected CVST. Anticoagulation therapy with low-molecular weight heparin should be initiated in patients with CVST immediately. After the acute stage, warfarin is recommended for 3-6 months to prevent the recurrence of CVST and other venous thromboembolic events.

Conclusions: The guideline summarises the current evidence regarding the management of CVST, and provides references for diagnosis, treatment and secondary prevention of CVST in China.

Keywords: MRI; brain; vein.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
The proposed algorithm for the diagnosis of cerebral venous sinus thrombosis (CVST). CTV, compute tomography venography. MRV, magnetic resonance venography. MRV, magnetic resonance venography. DSA, digital substraction angiography. CSF, cerebrospinal fluid.
Figure 2
Figure 2
The proposed algorithm for the treatment of cerebral venous sinus thrombosis (CVST). INR, international normalised ratio; LMWH, low-molecular weight heparin; UFH, unfractionated heparin.

References

    1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791–8. 10.1056/NEJMra042354
    1. Bousser M-G, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007;6:162–70. 10.1016/S1474-4422(07)70029-7
    1. Janghorbani M, Zare M, Saadatnia M, et al. . Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand 2008;117:117–21. 10.1111/j.1600-0404.2007.00915.x
    1. Weimar C, Masuhr F, Hajjar K. Diagnosis and treatment of cerebral venous thrombosis. Expert Rev Cardiovasc Ther 2012;10:1545–53. 10.1586/erc.12.126
    1. Filippidis A, Kapsalaki E, Patramani G, et al. . Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus 2009;27:E3. 10.3171/2009.8.FOCUS09167
    1. Medel R, Monteith SJ, Crowley RW, et al. . A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurg Focus 2009;27:E6. 10.3171/2009.8.FOCUS09154
    1. Chik Y, Gottesman RF, Zeiler SR, et al. . Differentiation of transverse sinus thrombosis from congenitally atretic cerebral transverse sinus with CT. Stroke 2012;43:1968–70. 10.1161/STROKEAHA.112.656124
    1. Rahman M, Velat GJ, Hoh BL, et al. . Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurg Focus 2009;27:E7. 10.3171/2009.7.FOCUS09146
    1. Saposnik G, Barinagarrementeria F, Brown RD, et al. . Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American heart Association/American stroke association. Stroke 2011;42:1158–92. 10.1161/STR.0b013e31820a8364
    1. Ghiasian M, Mansour M, Mazaheri S, et al. . Thrombosis of the cerebral veins and sinuses in Hamadan, West of Iran. J Stroke Cerebrovasc Dis 2016;25:1313–9. 10.1016/j.jstrokecerebrovasdis.2016.02.022
    1. Daif A, Awada A, al-Rajeh S, et al. . Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 1995;26:1193–5. 10.1161/01.str.26.7.1193
    1. Coutinho JM, Zuurbier SM, Aramideh M, et al. . The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 2012;43:3375–7. 10.1161/STROKEAHA.112.671453
    1. Devasagayam S, Wyatt B, Leyden J, et al. . Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke 2016;47:2180–2. 10.1161/STROKEAHA.116.013617
    1. Agnelli G, Verso M. Epidemiology of cerebral vein and sinus thrombosis. Front Neurol Neurosci 2008;23:16–22. 10.1159/000111258
    1. deVeber G, Andrew M, Adams C, et al. . Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417–23. 10.1056/NEJM200108093450604
    1. Ferro JM, Canhão P, Stam J, et al. . Prognosis of cerebral vein and dural sinus thrombosis: results of the International study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 2004;35:664–70. 10.1161/01.STR.0000117571.76197.26
    1. Ferro JM, Coutinho JM, Dentali F, et al. . Safety and efficacy of dabigatran etexilate vs Dose-Adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol 2019;76 10.1001/jamaneurol.2019.2764. [Epub ahead of print: 03 Sep 2019].

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever